SIGLEC10 and neoplasm: The macrophage‐expressed inhibitory receptor Siglec‐10 engages with tumor‐associated CD24 through interactions at its extracellular domain, which triggers intracellular signaling via immunoreceptor tyrosine‐based inhibitory motifs (ITIMs) located within its cytoplasmic tail [87].